论文部分内容阅读
最近在东京召开了题为“对医药品安全性的认识和对策”的小型讨论会,旨在对医药品的主要情况及其危险性认识的系统化,提高一般市民对医药品的信赖感。会议由瑞士汽巴嘉基公司主办,这是七国正在研究的“风险得益估计的药物分析和对策”(Risk/Benefit Assessment ofDrugs-Analysis and Response.RAD-AR)规划中的一部分。讨论如何收集、评价和传送医药品副作用的信息,会上由日本RAD-AR 专家组介绍日本的情况,日本RAD-AR 专家组由五部门专家组成,即医学、药学、社会心理学、经济学和风险学学者。
Recently, a small seminar entitled “Recognition and countermeasures for the safety of pharmaceuticals” was held in Tokyo. It aims to systematically recognize the main conditions and dangers of pharmaceuticals and to increase the general public’s trust in pharmaceutical products. The conference was hosted by Switzerland’s Ciba Gage, which is part of the “Risk/Benefit Assessment of Drugs-Analysis and Response. RAD-AR” program being studied by the seven countries. To discuss how to collect, evaluate and transmit information on the side effects of pharmaceutical products, the Japanese RAD-AR expert group introduced the situation in Japan, and the Japanese RAD-AR expert group consisted of five sector experts, namely, medicine, pharmacy, social psychology, and economics. And risk scholars.